Globe size influenced applanation tonometry readings. Hence, when the tonometry record does not fit the clinical findings, axial length measurement may help interpret its significance.
Purpose This short study aims at quantitatively correlating scale readings of the Goldmann tonometer to corneal curvatures in one and the same eye. Methods A total of 30 eyes of 21 adult patients who presented themselves in clinical practice for routine examination were arbitrarily selected. Corneal curvatures were measured in the horizontal and vertical meridians and then applanation tension measured in the same order. The data were submitted to statistical analysis by computer using Microsoft Excel and SAS System programs. Results All cases exhibited a strong positive correlation of tonometric readings to corneal curvature, that is, the flatter the curvature, the lower the reading on the scale of the tonomer, and vice versa. Conclusion The numbers on the scale of the Goldmann tonometer may not represent true intraocular pressure in mmHg because their values depend on a number of variables of the globe, including corneal astigmatism. Attention to these influences may help interpret the tonometric record in difficult cases.
.
Glaucoma as understood today could not have been detected before the means to see the optic nerve and reliably measure the intraocular pressure were available after the mid‐1850s. One form, however, manifested itself as a visible enlargement of the globe and was thus recognized since antiquity. This article traces the nomenclature, signs and symptoms, and treatment of buphthalmos from the ancient Greeks to the second half of the 19th century, when the present methods began.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.